医学
发病机制
细胞因子
糖尿病
免疫学
肿瘤坏死因子α
免疫系统
代谢综合征
生物信息学
内分泌学
生物
作者
Xiaoyan Xing,Xiaoyu Hu
标识
DOI:10.1016/j.it.2022.12.003
摘要
Cytokine release syndrome (CRS) is a severe clinical syndrome marked by drastic elevation of inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF). Despite the current empirical therapeutic strategies, prediction of CRS onset and identification of high-risk individuals are not satisfactory due to poor understanding of the mechanisms underlying CRS-related immune dysfunction and risk factors for CRS. Recent studies have suggested that conditions such as stress, obesity, diabetes, and hypertension may contribute to the development of CRS. Here, we discuss potential connections between these conditions and CRS pathogenesis, with a focus on stress hormone catecholamine-mediated effects, hoping that the design of CRS therapeutic approaches ensues from a renewed perspective.
科研通智能强力驱动
Strongly Powered by AbleSci AI